Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) management- Our Experience

Year : 2024 | Volume : | : | Page : –

Prof Dr Ravi Kumar Chittoria

  1. Professor, Department of Plastic Surgery JIPMER Puducherry India


Telogen effluvium, a condition of non-inflammatory, no scarring, diffuse hair loss after weight loss surgery. A through history taking and Videodermatoscopy is an effective tool for evaluation of a patient with weight loss surgery induced teleogen effluvium (We Loss SITE). Cyclical Nutritional Therapy, Low level laser therapy, Autologous Platelet Rich Plasma is an effective treatment for telogen effluvium. This case report shares our experience in management of a patient weight loss surgery induced telogen effluvium. An OPD visit was made by a 23-year-old male patient from Calicut, Kerala, who works as a driver and has had hair loss for two years following bariatric surgery. Since childhood, the patient has been obese. When she became pregnant, his mother had uncontrolled diabetes. At nine months old, she had a caesarean section because of macrosomia. When the patient was delivered, their weight was 6 kg. With age, he began to put on weight gradually. It might be challenging to differentiate between female pattern hair loss and telogen effluvium, a non-inflammatory, widespread hair loss disorder. The entire scalp usually experiences hair loss, albeit on occasion the temporal regions show the most signs of it. The hair-pull test is positive, with increased shedding of telogen hairs when telogen effluvium is active. In our patient with weight loss surgery induced telogen effluvium, videodermatoscopy was helpful for diagnosis autologous platelet rich plasma therapy, low intensity laser therapy, and cyclical nutritional therapy all contributed to the restoration of better hair.

Keywords: weight loss surgery, bariatric, videodermatoscopy, Low-level laser, cyclical nutritional therapy, platelet rich plasma, telogen effluvium

How to cite this article: Prof Dr Ravi Kumar Chittoria. Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) management- Our Experience. Recent Trends in Cosmetics. 2024; ():-.
How to cite this URL: Prof Dr Ravi Kumar Chittoria. Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) management- Our Experience. Recent Trends in Cosmetics. 2024; ():-. Available from: https://journals.stmjournals.com/rtc/article=2024/view=146345


  1. Thiedke CC. Alopecia in women. American family physician. 2003 Mar 1;67(5):1007-14.
  2. Mounsey AL, Reed SW. Diagnosing and treating hair loss. American family physician. 2009 Aug 15;80(4):356-62.
  3. Malkud S. Telogen effluvium: a review. Journal of clinical and diagnostic research: JCDR. 2015 Sep;9(9):WE01.
  4. Rebora A. Telogen effluvium: a comprehensive review. Clinical, cosmetic and investigational dermatology. 2019 Aug 21:583-90.
  5. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. Journal of the American Academy of Dermatology. 2006 Nov 1;55(5):799-806.
  6. Bernstein RM, Rassman WR. Densitometry and video-microscopy. InHair Transplant Forum International 2007 Mar 1 (Vol. 17, No. 2, pp. 41-51). Hair Transplant Forum International.
  7. Irwig MS. Persistent sexual side effects of finasteride: could they be permanent?. The journal of sexual medicine. 2012 Nov;9(11):2927-32.
  8. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. The journal of sexual medicine. 2011 Mar;8(3):872-84.
  9. Rajput Rajendrasingh RR. The concept of cyclical nutritional therapy for hair growth which can be applied for wellness.
  10. Roughead ZK, Zito CA, Hunt JR. Inhibitory effects of dietary calcium on the initial uptake and subsequent retention of heme and nonheme iron in humans: comparisons using an intestinal lavage method. The American journal of clinical nutrition. 2005 Sep 1;82(3):589-97.
  11. Brown Jr EB, Dubach R, Moore CV. Studies in iron transportation and metabolism. 11. Critical analysis of mucosal block by large doses of inorganic iron in human subjects. Journal of Laboratory and Clinical Medicine. 1958;52:335-55.
  12. Halliwell B. Antioxidants in human health and disease. Annual review of nutrition. 1996 Jul;16(1):33-50.
  13. Halliwell B. The antioxidant paradox. The lancet. 2000 Apr 1;355(9210):1179-80.
  14. Wang L, Li Q, Duan XL, Chang YZ. Effects of extracellular iron concentration on calcium absorption and relationship between Ca2+ and cell apoptosis in Caco-2 cells. World Journal of Gastroenterology: WJG. 2005 May 5;11(19):2916.
  15. Meydani M. Antioxidants in the prevention of chronic diseases. Nutrition in Clinical Care: an Official Publication of Tufts University. 2002 Mar 1;5(2):47-9.
  16. Rutkowski M, Grzegorczyk K. Adverse effects of antioxidative vitamins. International journal of occupational medicine and environmental health. 2012 Jun;25(2):105-21.
  17. Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatologic Surgery. 2014 Sep 1;40(9):1010-9.
  18. Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. American journal of clinical dermatology. 2014 Apr;15(2):115-27.
  19. Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device–controlled multicenter trial. Dermatologic Surgery. 2013 Aug 1;39(8):1177-83.

Ahead of Print Subscription Original Research
Received March 13, 2024
Accepted May 8, 2024
Published May 16, 2024